| Literature DB >> 29188029 |
Stéphane Verguet1, Gillian Tarr2, Cindy L Gauvreau3, Sujata Mishra4, Prabhat Jha4, Lingrui Liu1, Yue Xiao5, Yingpeng Qiu5, Kun Zhao5.
Abstract
BACKGROUND: Tobacco taxation and smoke-free workplaces reduce smoking, tobacco-related premature deaths and associated out-of-pocket health care expenditures. We examine the distributional consequences of a price increase in tobacco products through an excise tax hike, and of an implementation of smoke-free workplaces, in China.Entities:
Mesh:
Year: 2017 PMID: 29188029 PMCID: PMC5681709 DOI: 10.7189/jogh.07.020701
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Inputs used in the modeling of the expansion of tobacco control policies in China.
| Input | Value | Source |
|---|---|---|
| Male population by age group | • 0–4 y–olds: 46 223 844 | [ |
| • 5–9 y–olds: 42 116 819 | ||
| • 10–14 y–olds: 44 333 255 | ||
| • 15–19 y–olds: 57 372 413 | ||
| • 20–24 y–olds: 69 787 588 | ||
| • 25–29 y–olds: 54 148 396 | ||
| • 30–34 y–olds: 48 300 078 | ||
| • 35–39 y–olds: 60 477 911 | ||
| • 40–44 y–olds: 62 353 282 | ||
| • 45–49 y–olds: 52 513 698 | ||
| • 50–54 y–olds: 41 888 301 | ||
| • 55–59 y–olds: 41 743 573 | ||
| • 60–64 y–olds: 28 223 579 | ||
| • 65–69 y–olds: 19 966 448 | ||
| • 70–74 y–olds: 15 697 892 | ||
| • 75–79 y–olds: 10 754 066 | ||
| • 80–84 y–olds: 5 524 515 | ||
| • ≥85 y–olds: 2 757 397 | ||
| Smoking prevalence per age group (% of male population) | • 15–19 y–olds: 14.0% | Authors’ calculations based on [ |
| • 20–24 y–olds: 48.8% | ||
| • 25–29 y–olds: 53.0% | ||
| • 30–34 y–olds: 52.2% | ||
| • 35–39 y–olds: 57.5% | ||
| • 40–44 y–olds: 68.0% | ||
| • 45–49 y–olds: 66.7% | ||
| • 50–54 y–olds: 58.0% | ||
| • 55–59 y–olds: 57.7% | ||
| • 60–64 y–olds: 47.3% | ||
| • 65–69 y–olds: 37.6% | ||
| • 70–74 y–olds: 21.0% | ||
| • 75–79 y–olds: 19.0% | ||
| • 80–84 y–olds: 17.0% | ||
| • ≥85 y–olds: 13.0% | ||
| Relative smoking prevalence per income quintile | • Income quintiles I to IV: 1.14 times average per age group | [ |
| • Income quintile V: 0.86 times average per age group | ||
| Cigarette consumption (cigarettes per day) per income quintile | • Income quintile I to V: 15.6, 15.5, 13.8, 12.7, 12.7 | [ |
| Price per pack (20 cigarettes) (2015 US$) | • US$ 2.00 (before excise tax increase) | [ |
| • US$ 3.50 (after excise tax increase) | ||
| Taxes per pack (20 cigarettes) (2015 US$) | • US$ 1.12 (before: 56% of retail price) | [ |
| • US$ 2.63 (after: 75% of retail price) | ||
| Relative smoking prevalence reduction among workers after workplace smoking ban | • 9% | [ |
| Proportion of deaths among smokers attributable to smoking | • 0.50 | [ |
| Reduction of smoking–attributable death risk by age at quitting | • 15–19 y–olds: 96.9% | Authors’ derivations based on [ |
| • 20–24 y–olds: 94.8% | ||
| • 25–29 y–olds: 92.1% | ||
| • 30–34 y–olds: 89.2% | ||
| • 35–39 y–olds: 86.6% | ||
| • 40–44 y–olds: 83.7% | ||
| • 45–49 y–olds: 79.5% | ||
| • 50–54 y–olds: 72.9% | ||
| • 55–59 y–olds: 62.8% | ||
| • 60–64 y–olds: 49.9% | ||
| • 65–69 y–olds: 36.4% | ||
| • 70–74 y–olds: 24.7% | ||
| • 75–79 y–olds: 15.7% | ||
| • 80–84 y–olds: 9.1% | ||
| • ≥85 y–olds: 4.5% | ||
| Proportion of smoking–attributable deaths per cause of death | • COPD: 11.3% | [ |
| • Stroke: 45.5% | ||
| • Heart disease: 22.8% | ||
| • Neoplasm: 20.4% | ||
| Tobacco–related disease treatment costs (2015 US$) | • COPD: US$ 2256 | [ |
| • Stroke: US$ 2197 | ||
| • Heart disease: US$ 11 774 | ||
| • Neoplasm: US$ 14 794 | ||
| Utilization of health care by tobacco–related disease (%) | • COPD: 33% | [ |
| • Stroke: 80% | ||
| • Heart disease: 81% | ||
| • Neoplasm: 50% | ||
| Relative utilization of health care per income quintile | • Income quintile I to V: (0.79, 0.98, 1.00, 1.08, 1.15) times average (applies to % above) | [ |
| Fraction of health care costs reimbursed by insurance schemes | • 48% | Authors’ derivation based on [ |
| Annual income per capita (2015 US$) | • Income quintile I: 0 to US$ 992 | Income distribution based on average per capita income of US$ 3039 and Gini coefficient of 0.43 [ |
| • Income quintile II: US$ 992 to 1870 | ||
| • Income quintile III: US$ 1870 to 2973 | ||
| • Income quintile IV: US$ 2973 to 4718 | ||
| • Income quintile V: > US$ 4718 | ||
| Assumed price elasticity of demand for cigarette by age group (≥25 y–olds; 15–24 y–olds; future smokers ie, under 15 y–olds) and income quintile | • Income quintile I: –0.64; –1.28; –1.28 | |
| • Income quintile II: –0.51; –1.02; –1.02 | ||
| • Income quintile III: –0.38; –0.76; –0.76 | ||
| • Income quintile IV: –0.25; –0.50; –0.50 | ||
| • Income quintile V: –0.12; –0.24; –0.24 |
COPD, chronic obstructive pulmonary disease, y – year, d – day
Figure 1Impact of tobacco control policies (75% increase in the retail price of cigarettes through excise tax; workplace total smoking bans) in China, per income quintile, on the number of tobacco–related premature deaths averted.
Figure 2Impact of tobacco control policies (75% increase in the retail price of cigarettes through excise tax; workplace total smoking bans) in China, per income quintile, on the net change in annual tax revenues collected on cigarette sales among current smokers (15 years of age and above).
Figure 3Impact of tobacco control policies (75% increase in the retail price of cigarettes through excise tax; workplace total smoking bans) in China, per income quintile, on the amount of out–of–pocket tobacco–related disease treatment costs averted.
Figure 4Impact of tobacco control policies (75% increase in the retail price of cigarettes through excise tax; workplace total smoking bans) in China, per income quintile, on the number of tobacco–related poverty cases averted due to the prevention of out–of–pocket tobacco–related disease treatment costs.
Figure 5Impact of tobacco control policies (75% increase in the retail price of cigarettes through excise tax; workplace total smoking bans) in China, per income quintile, on the number of tobacco–related cases of catastrophic expenditures averted due to the prevention of out–of–pocket tobacco–related disease treatment costs.
Figure 6Impact of a 75% increase in the retail price of cigarettes through excise tax (proportion of smokers switching to cheaper cigarette brands, ie, “switchers”, was set at either 0%, 33%, or 75%) in China, per income quintile, on: the number of tobacco–related premature deaths averted (a); the net change in annual tax revenues collected on cigarette sales among current smokers (15 years of age and above) (b); the amount of out–of–pocket tobacco–related disease treatment costs averted (c); the number of tobacco–related poverty cases averted due to the prevention of out–of–pocket tobacco–related disease treatment costs (d); and the number of tobacco–related cases of catastrophic expenditures averted due to the prevention of out–of–pocket tobacco–related disease treatment costs (e).